Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A gastrin-producing neuroendocrine tumor that arises from the duodenum. It is characterized by the presence of uniform cells that form pseudorosettes. The neoplastic cells have uniform nuclei and small amount of eosinophilic cytoplasm.
No clinical trials have been registered for duodenal gastrin-producing neuroendocrine tumor.
18 publications have been identified in PubMed for duodenal gastrin-producing neuroendocrine tumor. Research spans Case Report / Case Series (39%), Review / Meta-Analysis (28%), and Basic Science / Preclinical (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 39% |
Data assembled from 2 of 12 sources · Last updated Sep 17, 2026, 9:52 PM UTC
Research summaries
5 |
28% |
Laboratory research | 2 | 11% |
Disease patterns and progression | 2 | 11% |
Clinical study results | 1 | 6% |
New treatment approaches | 1 | 6% |
Sato S (2026). [PMID: 41760078](https://pubmed.ncbi.nlm.nih.gov/41760078/). *Medicine*. [Case Report / Case Series]
Prosapio JG (2026). [PMID: 30521243](https://pubmed.ncbi.nlm.nih.gov/30521243/). *Unknown Journal*. [Basic Science / Preclinical]
Helbing A (2026). [PMID: 28722872](https://pubmed.ncbi.nlm.nih.gov/28722872/). *Unknown Journal*. [Review / Meta-Analysis]
Miyata T (2026). [PMID: 41945253](https://pubmed.ncbi.nlm.nih.gov/41945253/). *Clin J Gastroenterol*. [Case Report / Case Series]
Gaujoux S (2026). [PMID: 41862416](https://pubmed.ncbi.nlm.nih.gov/41862416/). *World journal of surgery*. [Clinical Trial Publication]
Kämmerer D (2026). [PMID: 42213095](https://pubmed.ncbi.nlm.nih.gov/42213095/). *Chirurgie (Heidelb)*. [Review / Meta-Analysis]
Vanoli A (2025). [PMID: 40347392](https://pubmed.ncbi.nlm.nih.gov/40347392/). *Endocrine pathology*. [Epidemiology / Natural History]
Di Franco M (2025). [PMID: 40458720](https://pubmed.ncbi.nlm.nih.gov/40458720/). *Frontiers in oncology*. [Case Report / Case Series]
Ghosh R (2025). [PMID: 41018051](https://pubmed.ncbi.nlm.nih.gov/41018051/). *Journal of the Endocrine Society*. [Gene Therapy / Novel Therapeutics]
Sahithi PVL (2025). [PMID: 40291307](https://pubmed.ncbi.nlm.nih.gov/40291307/). *Cureus*. [Case Report / Case Series]
AI-curated news mentioning duodenal gastrin-producing neuroendocrine tumor
Updated Feb 28, 2026
A recent study identifies positive margins and lymphovascular invasion as significant risk factors for remnant tumors or late recurrence in patients undergoing endoscopic or local resection of duodenal neuroendocrine tumors. These findings could inform surgical approaches and post-operative monitoring strategies.